Digital therapeutic maker Happify Well being is partnering with neuroscience-focused pharma firm Biogen on a digital engagement and schooling platform for a number of sclerosis.
The product will embrace Happify’s neighborhood for individuals residing with MS, in addition to entry to neurology suppliers like medical doctors and nurses, psychological well being professionals, dietitians and rehabilitation professionals. Biogen will contribute instructional content material and affected person care sources.
“This collaboration is one in all some ways we’re targeted on supporting sufferers by assembly them the place they’re. The mix of Biogen’s experience in neuroscience and our dedication to digital well being, together with Happify Well being’s AI and digital therapeutic capabilities, will assist drive a related and complete expertise that enables sufferers to really feel supported all through their journey,” Jason Hawbecker, head of strategic partnerships and collaborations at Biogen, mentioned in a press release.
“We’re excited in regards to the potential of this partnership to offer general help for the MS neighborhood.”
WHY IT MATTERS
In keeping with the Nationwide A number of Sclerosis Society, practically a million individuals have MS within the U.S. The illness could cause signs like numbness or tingling, weak point, issue strolling, imaginative and prescient issues and dizziness.
Happify is pitching the collaboration as a means to enhance a affected person’s care journey and preserve them knowledgeable about their situation.
“It may be difficult for individuals residing with MS to remain up-to-date with the newest remedies, interpret new signs or examine adjustments of their well being that will or will not be associated to MS,” Ofer Leidner, president of Happify Well being, mentioned in a press release.
“We’re offering the MS neighborhood with an answer configured to accommodate their particular wants, in addition to alternatives to have interaction with consultants, obtain curated content material and talk about illness administration with different neighborhood members. We’re very excited to companion with Biogen on this chance given their management within the MS house.”
THE LARGER TREND
Happify has been on a partnership tear in latest months. Earlier this month, the digital therapeutic firm introduced a collaboration that’s targeted on ladies’s well being with insurer Anthem, which is quickly to be rebranded to Elevance Well being.
In March, Happify entered into an settlement with healthcare-services and pharmaceutical firm Zuellig Pharma to commercialize two of its prescription digital therapeutics in Asia.
The startup additionally lately launched a digital program for individuals with psoriasis in Spain, Italy and the U.Ok. as a part of a partnership with Barcelona-based pharma firm Almirall. Happify additionally closed a $73 million Collection D funding spherical in March 2021.
Biogen is not new to the digital well being house both. In Might, it entered right into a licensing settlement with prescription digital therapeutics startup MedRhythms to develop and commercialize its MR-004 product, which goals to enhance mobility for individuals with a number of sclerosis.
#Happify #Well being #companions #Biogen #a number of #sclerosis #affected person #engagement #device